USE OF SYNERGISTIC COMPOSITIONS OF IL-12 AND IFN-ALPHA FOR THE TREATMENT OF INFECTIOUS DISEASES

The present invention provides a combination of IL-12 and IFN alpha together with a pharmaceutically acceptable carrier useful for treatment and prophylaxis of infectious diseases, preferably chronic infectious diseases and more preferably viral infections, e.g. HSV, HIV, Hepatitis B, Hepatitis C, p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ALBER, GOTTFRIED, PALMER, KATHRIN, MATTNER, FRANK, ALBERT, ROGERSON, JANE, ANDRE, LOUISE, CARR, JACQUELINE, ANNE, MULQUEEN, MICHAEL, JOHN
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a combination of IL-12 and IFN alpha together with a pharmaceutically acceptable carrier useful for treatment and prophylaxis of infectious diseases, preferably chronic infectious diseases and more preferably viral infections, e.g. HSV, HIV, Hepatitis B, Hepatitis C, papilloma etc., bacterial infections, e.g. tuberculosis, salmonellosis, listeriosis, etc., and parasite infections, e.g. malaria, leishmaniasis, and schistosomiasis. These compositions are characterized by the synergistic interaction of IL-12 and IFN alpha . The present invention also provides the use of the above combination for the treatment and prophylaxis of infectious diseases.